Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.51ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.51ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.51NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.308ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.308ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.308ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.308NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.138ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.138ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.138ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.138NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.379ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.379ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.379ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.379NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.240ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.240ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.240ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.240NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.240.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.240.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.240.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.240.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.121.1 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.121.1 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
AY.121.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
AY.121.1 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-6672.85US
B.1.1.46ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.46ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.46ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.46NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.44ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.44ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.44ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.44NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KC.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KC.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KC.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KC.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KL.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KL.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KL.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KL.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HC.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HC.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HC.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HC.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used